- Home
- NIM vs THTX Comparison
NIM vs THTX Comparison
Compare NIM & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIM
- THTX
- Stock Information
- Founded
- NIM 1992
- THTX 1993
- Country
- NIM United States
- THTX Canada
- Employees
- NIM N/A
- THTX N/A
- Industry
- NIM Trusts Except Educational Religious and Charitable
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- NIM Finance
- THTX Health Care
- Exchange
- NIM Nasdaq
- THTX Nasdaq
- Market Cap
- NIM 112.4M
- THTX 119.1M
- IPO Year
- NIM N/A
- THTX N/A
- Fundamental
- Price
- NIM $8.98
- THTX $2.53
- Analyst Decision
- NIM
- THTX Hold
- Analyst Count
- NIM 0
- THTX 1
- Target Price
- NIM N/A
- THTX N/A
- AVG Volume (30 Days)
- NIM 35.4K
- THTX 139.5K
- Earning Date
- NIM 01-01-0001
- THTX 07-09-2025
- Dividend Yield
- NIM 3.46%
- THTX N/A
- EPS Growth
- NIM N/A
- THTX N/A
- EPS
- NIM N/A
- THTX N/A
- Revenue
- NIM N/A
- THTX $88,666,000.00
- Revenue This Year
- NIM N/A
- THTX N/A
- Revenue Next Year
- NIM N/A
- THTX $15.13
- P/E Ratio
- NIM N/A
- THTX N/A
- Revenue Growth
- NIM N/A
- THTX 13.52
- 52 Week Low
- NIM $8.28
- THTX $1.12
- 52 Week High
- NIM $9.74
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- NIM 41.65
- THTX 49.00
- Support Level
- NIM $8.96
- THTX $2.38
- Resistance Level
- NIM $9.10
- THTX $2.68
- Average True Range (ATR)
- NIM 0.08
- THTX 0.09
- MACD
- NIM 0.00
- THTX -0.02
- Stochastic Oscillator
- NIM 5.94
- THTX 51.72
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.